OCUTF (Ocumension Therapeutics) FCF Margin %: -29.42% (As of Dec. 2025)


OCUTF Ocumension Therapeutics OCUTF
52 GF Score
Price $0.70
GF Value $2.82
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Ocumension Therapeutics FCF Margin %?

Ocumension Therapeutics OCUTF 52 FCF Margin % is -29.42% as of Dec. 2025. GuruFocus rates OCUTF with a GF Score™ of 52/100 and a GF Value™ of $2.82 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 959 Biotechnology companies, Ocumension Therapeutics ranks better than 55.79% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Ocumension Therapeutics's Free Cash Flow for the six months ended in Dec. 2025 was $-21.3 Mil. Ocumension Therapeutics's Revenue for the six months ended in Dec. 2025 was $72.5 Mil. Therefore, Ocumension Therapeutics's FCF Margin % for the quarter that ended in Dec. 2025 was -29.42%.

As of today, Ocumension Therapeutics's current FCF Yield % is -10.02%.

The historical rank and industry rank for Ocumension Therapeutics's FCF Margin % or its related term are showing as below:

OCUTF' s FCF Margin % Range Over the Past 10 Years
Min: -57406.16   Med: -321.26   Max: -44.4
Current: -44.4

During the past 8 years, the highest FCF Margin % of Ocumension Therapeutics was -44.40%. The lowest was -57406.16%. And the median was -321.26%.

OCUTF's FCF Margin % is ranked better than
55.79% of 959 companies
in the Biotechnology industry
Industry Median: -84.65 vs OCUTF: -44.40

Ocumension Therapeutics FCF Margin % Related Terms

Ocumension Therapeutics FCF Margin % Historical Data

* Premium members only.

The historical data trend for Ocumension Therapeutics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ocumension Therapeutics FCF Margin % Chart

Ocumension Therapeutics Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial -1,534.69 -321.26 -219.10 -98.00 -44.59

Ocumension Therapeutics Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -170.05 -133.64 -74.08 -70.91 -29.42

OCUTF vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, Ocumension Therapeutics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ocumension Therapeutics FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ocumension Therapeutics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Ocumension Therapeutics's FCF Margin % falls into.


OCUTF
52GF Score
Ocumension Therapeutics OCUTF
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ocumension Therapeutics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Ocumension Therapeutics's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-50.922/114.203
=-44.59 %

Ocumension Therapeutics's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-21.319/72.456
=-29.42 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -29.42% mean?
Ocumension Therapeutics (OCUTF) has a FCF Margin % of -29.42% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Ocumension Therapeutics and its competitors. According to the industry distribution chart, Ocumension Therapeutics ranks #424 out of 959 companies in the Biotechnology industry, placing it in the top 44.2%.
Is Ocumension Therapeutics' FCF Margin % too high?
Ocumension Therapeutics' current FCF Margin % is -29.42%. Based on the distribution chart, Ocumension Therapeutics ranks #424 out of 959 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Ocumension Therapeutics has a GF Score™ of 52/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Ocumension Therapeutics' FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Ocumension Therapeutics ranks #424 out of 959 companies for FCF Margin %. This puts Ocumension Therapeutics in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Ocumension Therapeutics and its competitors. Ocumension Therapeutics's current FCF Margin % is -29.42%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ocumension Therapeutics stock overvalued right now?
Based on GuruFocus' analysis, Ocumension Therapeutics (OCUTF) is currently considered Possible Value Trap. The stock's GF Value™ is $2.82, compared to a current price of $0.70 — trading 75.2% below its estimated fair value. The current FCF Margin % is -29.42%. Ocumension Therapeutics' overall GF Score™ is 52/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Ocumension Therapeutics (OCUTF), the current FCF Margin % is -29.42% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ocumension Therapeutics (OCUTF) Overvalued in 2026?

Based on GuruFocus' analysis, Ocumension Therapeutics stock appears to be undervalued. The current stock price of $0.70 is trading 75.2% below its estimated GF Value™ of $2.82. GuruFocus considers Ocumension Therapeutics to be Possible Value Trap.

Key valuation signals for OCUTF:

  • FCF Margin %: -29.42%
  • GF Value™: $2.82 vs. price of $0.70 (75.2% below fair value)
  • GF Score™: 52/100 with 5 warning signs

No single metric tells the full story. See the OCUTF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ocumension Therapeutics Business Description

Other Exchanges 01477:Hong Kong5DG:Germany
Address No. 1858 Yinzhongnan Road, Guoxiang Subdistrict, Wuzhong District, Suzhou, Jiangsu, CHN
Ocumension Therapeutics is an ophthalmic pharmaceutical platform company identifying, developing, and commercializing ophthalmic therapies. It provides a pharmaceutical total solution to address unmet ophthalmic medical needs in China. Its product candidates include OT-401 (YUTIQ), OT-101, OT-301 (NCX 470), OT-1001 (ZERVIATE), OT-502 (DEXYCU), OT-202, OT-503 (NCX 4251), OT-701, Ou Qin, Brimonidine tartrate eye drop, 0.5% moxifloxacin eye drop, OT-601-C, OT-302, OT-1301, T-1601, and OT-1602.
52GF Score

Get the complete analysis for OCUTF

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.70
Price
$2.82
GF Value